Stryker Corporation revenue
Stryker Corporation's revenue was $25.12bn in fiscal 2025, up 11.2% on the year before. Since fiscal 2009 ($6.72bn) it has grown at a compound 8.6% a year. Over the last twelve months it was $26.30bn.
Revenue history
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.7 | 7.3 | 8.3 | 8.7 | 9.0 | 9.7 | 9.9 | 11.3 | 12.4 | 13.6 | 14.9 | 14.4 | 17.1 | 18.4 | 20.5 | 22.6 | 25.1 | 26.3 |
| Growth on the year before | — | +8.9% | +13.5% | +4.2% | +4.2% | +7.2% | +2.8% | +13.9% | +9.9% | +9.3% | +9.4% | −3.6% | +19.2% | +7.8% | +11.1% | +10.2% | +11.2% | — |
| Gross profit | 4.5 | 5.0 | 5.5 | 5.9 | 6.0 | 6.4 | 6.6 | 7.5 | 8.2 | 8.9 | 9.7 | 9.1 | 11.0 | 11.6 | 13.1 | 14.4 | 16.1 | 17.2 |
| Gross margin | 67.5% | 68.8% | 66.2% | 67.9% | 66.7% | 65.7% | 66.4% | 66.3% | 65.7% | 65.7% | 65.1% | 63.1% | 64.1% | 62.8% | 63.7% | 63.9% | 64.0% | 65.3% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Med Surg and Neurotechnology | $15.6B | 62.3% | ▲ 15.7% |
| Orthopaedics and Spine | $9.5B | 37.7% | ▲ 4.3% |
| Region | Revenue | Share | YoY |
|---|---|---|---|
| United States | $19B | 75.7% | ▲ 12.2% |
| Outside the US | $6.1B | 24.3% | ▲ 8.1% |
| EMEA (part of Outside the US) | $3.2B | 52.1% | ▲ 9.8% |
| Asia Pacific (part of Outside the US) | $2.2B | 35.4% | ▲ 7.1% |
| Other Foreign Countries (part of Outside the US) | $765M | 12.5% | ▲ 4.1% |
From Stryker Corporation's 10-K filed February 11, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Stryker Corporation | $26.30bn | 7.9% | 9.8% |
| GE HealthCare | $21.64bn | 6.9% | 3.9% |
| Boston Scientific | $21.07bn | 8.9% | 15.3% |
| Koninklijke Philips NV | $20.16bn | 3.4% | — |
| Medtronic | $37.54bn | 9.8% | 6.0% |
| Abbott Laboratories | $46.59bn | 8.1% | 5.0% |
Compare with peers
- GE HealthCare revenue
- Boston Scientific revenue
- Koninklijke Philips NV revenue
- Medtronic revenue
- Abbott Laboratories revenue
Head to head: GEHC vs SYKBSX vs SYKPHG vs SYKMDT vs SYK
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies